Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2379]
News [5075]
Articles [208]
Editorials [8]
Conferences [138]
elearning [14]
An AI-derived digital pathology-based biomarker to predict the benefit of ADT...
Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022
Survival outcomes of unilateral RB based on pathological risk stratification...
Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research...
Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )
1 Mar 2022
SG in combination with pembro in patients with mUC who progressed after...
Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
SG in combination with pembro in patients with mUC who progressed after platinum (PLT)-based regimens ( Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA )
28 Feb 2022
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion
Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )
28 Feb 2022
Latest developments in mHSPC
Prof Kurt Miller and Prof Laura-Maria Krabbe
Latest developments in mHSPC ( Prof Kurt Miller and Prof Laura-Maria Krabbe )
25 Feb 2022
ASCO GU 2022: The latest in CRPC, including PARP combo data
Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel...
ASCO GU 2022: The latest in CRPC, including PARP combo data ( Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel Merseburger )
25 Feb 2022
Challenges and perspective of cancer patients during the COVID-19 pandemic and...
Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon
Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis ( Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon )
24 Feb 2022
Tailoring radiation therapy in the 21st century
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Tailoring radiation therapy in the 21st century ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
23 Feb 2022
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer...
Dr Diana Artene - American Society for Nutrition, Bucharest, Romania
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients ( Dr Diana Artene - American Society for Nutrition, Bucharest, Romania )
23 Feb 2022
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in...
Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC ( Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
21 Feb 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022
The global impact of the FDA's changing approval standards
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The global impact of the FDA's changing approval standards ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
2 Feb 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation